Srpt investor alert: robbins geller rudman & dowd llp announces that sarepta therapeutics, inc. investors with substantial losses have opportunity to lead the sarepta class action lawsuit

San diego--(business wire)--the suit alleges defendants issued false statements concerning sarepta business and prospects, resulting in its stock trading at inflated prices.

SRPT Ratings Summary

SRPT Quant Ranking